ICD-10 Coding for Atorvastatin Use and Adverse Effects(T46.6T, T46.6X, Z79.899)
Comprehensive guide on ICD-10 coding for atorvastatin use and adverse effects, including documentation requirements and coding pitfalls.
Complete code families applicable to Atorvastatin Use and Adverse Effects
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| T46.6X5A | Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter | Use when a patient experiences an adverse effect from atorvastatin. |
|
| Z79.899 | Other long term (current) drug therapy | Use for patients on long-term atorvastatin therapy. |
|
| Z91.130 | Patient's intentional underdosing of medication regimen due to side effects | Use when a patient intentionally reduces atorvastatin dosage due to side effects. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutAtorvastatin Use and Adverse Effects
Alternative codes to consider when ruling out similar conditions
Use for follow-up visits after initial adverse effect treatment.
Documentation & Coding Risks
Avoid these common issues when documenting Atorvastatin Use and Adverse Effects.
Using Z79.899 for short-term atorvastatin therapy
Impact
Clinical: Misrepresents patient therapy duration., Regulatory: Non-compliance with coding standards., Financial: Potential claim rejections.
Mitigation
Verify therapy duration before coding, Educate staff on correct code usage
Incorrect sequencing of adverse effect codes
Impact
Reimbursement: Incorrect sequencing can lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation
Always sequence T46.6X5A before the primary diagnosis code when documenting adverse effects.
Adverse effect documentation
Impact
Inadequate documentation of adverse effects can lead to audit issues.
Mitigation
Ensure detailed documentation of symptoms and lab results.
Frequently Asked Questions
Primary Code
Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter5AOther long term (current) drug therap